Subsequent Events (Details)				3 Months Ended
	May 12, 2017 USD ($) guarantor $ / shares shares	May 11, 2017 shares	Mar. 28, 2016 USD ($) $ / shares	May 12, 2017 USD ($) guarantor $ / shares shares	May 02, 2017 $ / shares	Mar. 31, 2017 USD ($) $ / shares shares	Dec. 31, 2016 USD ($) $ / shares shares	Nov. 15, 2016 USD ($)	Jun. 15, 2016 $ / shares	Apr. 29, 2016 USD ($)
Subsequent Event [Line Items]
Common stock, shares outstanding (in shares) | shares						12,167,349	10,103,525
Term loan balance						$ 6,686,000	$ 5,821,000
Number of warrants to purchase shares issued (in shares) | shares						543,479
Common stock, par value (in dollars per share) | $ / shares						$ 0.04	$ 0.04		$ 0.04
Loans payable | Credit agreement
Subsequent Event [Line Items]
Term loan balance						$ 3,676,000	$ 3,676,000
Debt covenant, minimum aggregate revenue for twelve months period ending each fiscal period thereafter								$ 42,000,000
Debt covenant, minimum EBITDA amount for the twelve month period ending December 31, 2017								500,000
Debt covenant, minimum EBITDA amount for the twelve month period ending March 31, 2018								900,000
Debt covenant, minimum EBITDA amount for the twelve month period ending June 30, 2018								2,500,000
Value of stock issued			$ 100,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.04
Line of credit | Credit agreement
Subsequent Event [Line Items]
Debt covenant, minimum aggregate revenue for three months period ending June 30, 2017								41,000,000
Line of credit | 2016 Credit and Security Agreement
Subsequent Event [Line Items]
Term loan balance						3,991,000	$ 3,603,000
Maximum borrowing capacity										$ 7,000,000
Debt covenant, minimum aggregate revenue for three months period ending June 30, 2017								41,000,000
Debt covenant, minimum aggregate revenue for twelve months period ending each fiscal period thereafter								42,000,000
Debt covenant, minimum EBITDA amount for the twelve month period ending December 31, 2017								500,000
Debt covenant, minimum EBITDA amount for the twelve month period ending March 31, 2018								900,000
Debt covenant, minimum EBITDA amount for the twelve month period ending June 30, 2018								$ 2,500,000
Piper Merger Corp., Provant Health Solutions, LLC and Wellness Holdings, LLC | Loans payable | Credit agreement
Subsequent Event [Line Items]
Term loan balance						3,700,000
Piper Merger Corp., Provant Health Solutions, LLC and Wellness Holdings, LLC | Line of credit | 2016 Credit and Security Agreement
Subsequent Event [Line Items]
Maximum borrowing capacity						$ 7,000,000.0
Subsequent event
Subsequent Event [Line Items]
Common stock, par value (in dollars per share) | $ / shares					$ 0.04
Subsequent event | Piper Merger Corp., Provant Health Solutions, LLC and Wellness Holdings, LLC
Subsequent Event [Line Items]
Shared to be issued in acquisition (up to amount) (in shares) | shares		10,448,849
Common stock, shares outstanding (in shares) | shares		25,500,000
Number of warrants to purchase shares issued (in shares) | shares	543,479			543,479
Value of stock issued	$ 1,300,000			$ 3,200,000
Warrants strike price (in dollars per share) | $ / shares	$ 0.84			$ 1.35
Stocks issued (in shares) | shares				4,025,000
Sale of stock, price per share (in dollars per share) | $ / shares	0.80			$ 0.80
Exercise price of warrant (in dollars per share) | $ / shares	$ 0.50			$ 0.50
Option indexed to issue shares (in shares) | shares	280,000			280,000
Option indexed, term to issue shares	90 days
Subsequent event | Piper Merger Corp., Provant Health Solutions, LLC and Wellness Holdings, LLC | Loans payable | Credit agreement
Subsequent Event [Line Items]
Term loan balance	$ 6,500,000			$ 6,500,000
Debt covenant, minimum EBITDA amount for the twelve month period ending December 31, 2017	3,000,000			3,000,000
Debt covenant, minimum EBITDA amount for the twelve month period ending March 31, 2018	5,000,000			5,000,000
Debt covenant, minimum EBITDA amount for the twelve month period ending June 30, 2018	5,200,000			5,200,000
Debt covenant, minimum EBITDA amount for the twelve month period ending September 30, 2018	6,000,000			6,000,000
Debt covenant, minimum EBITDA amount for the twelve month period ending December 31, 2018	8,000,000			8,000,000
Debt covenant, minimum EBITDA amount for the twelve month ending each fiscal year thereafter	9,000,000			9,000,000
Minimum consolidated unencumbered liquid assets required on last day of fiscal quarter ended June 30, 2017	500,000			500,000
Minimum consolidated unencumbered liquid assets required on last day of fiscal quarter ended September 30, 2017	750,000			750,000
Minimum consolidated unencumbered liquid assets required on last day of any fiscal quarter thereafter	1,000,000			1,000,000
Subsequent event | Piper Merger Corp., Provant Health Solutions, LLC and Wellness Holdings, LLC | Line of credit | Credit agreement
Subsequent Event [Line Items]
Debt covenant, minimum aggregate revenue for three months period ending June 30, 2017	10,500,000			10,500,000
Debt covenant, minimum aggregate revenue for six months period ending September 30, 2017	26,000,000			26,000,000
Debt covenant, minimum aggregate revenue for nine months period ending December 31, 2017	53,000,000			53,000,000
Debt covenant, minimum aggregate revenue for twelve months period ending March 31, 2018	69,000,000			69,000,000
Debt covenant, minimum aggregate revenue for twelve months period ending June 30, 2018	70,000,000			70,000,000
Debt covenant, minimum aggregate revenue for twelve months period ending September 30, 2018	71,000,000			71,000,000
Debt covenant, minimum aggregate revenue for twelve months period ending December 31, 2018	74,000,000			74,000,000
Debt covenant, minimum aggregate revenue for twelve months period ending each fiscal period thereafter	75,000,000			75,000,000
Subsequent event | Piper Merger Corp., Provant Health Solutions, LLC and Wellness Holdings, LLC | Line of credit | 2016 Credit and Security Agreement
Subsequent Event [Line Items]
Maximum borrowing capacity	10,000,000.0			10,000,000.0
Line of credit facility, capacity available during high-volume months	$ 15,000,000.0			$ 15,000,000.0
Subsequent event | Piper Merger Corp., Provant Health Solutions, LLC and Wellness Holdings, LLC | Affiliated Entity
Subsequent Event [Line Items]
Ownership percentage by noncontrolling owners		49.00%
Subsequent event | Piper Merger Corp., Provant Health Solutions, LLC and Wellness Holdings, LLC | Guarantor Subsidiaries | Line of credit | Revolving Credit Facility
Subsequent Event [Line Items]
Number of guarantors | guarantor	1			1
Maximum borrowing capacity	$ 2,000,000.0			$ 2,000,000.0